The full exemption of GST on individual health insurance premiums effective September 22, 2025 has triggered a remarkable behavioural shift, with Indians opting for substantially higher coverage. Policybazaar’s latest 2025 report reveals the average sum insured rising 31% from ₹14.5 lakh pre-exemption to ₹19 lakh post-exemption, as buyers channel savings into stronger protection amid escalating medical costs.
Glimpse:
Post-GST removal, demand for policies above ₹25 lakh surged 85%, while those in ₹10-25 lakh bracket grew 47%; sub-₹10 lakh covers dropped 24%. Tier-3 cities led penetration growth (share up to 70%), multi-year plans gained traction, and common claims highlighted heart ailments, cancer, and cataracts underscoring the need for comprehensive shields in a post-pandemic era.
When the GST Council slashed the 18% tax on individual health and life insurance premiums to zero effective September 22, 2025 it wasn’t just a fiscal tweak; it unleashed a quiet revolution in how Indians safeguard their health. Fast-forward to late 2025, and Policybazaar’s year-end analysis paints a vivid picture: savings from the exemption aren’t vanishing into pockets they’re fueling a decisive upgrade in coverage depth.
The numbers tell a compelling tale. Average sum insured leaped 31%, climbing from ₹14.5 lakh in the pre-exemption phase to ₹19 lakh afterward. This isn’t mere inflation adjustment; it’s a strategic pivot. Policies in the ₹10-25 lakh range swelled by 47%, while those offering ₹25 lakh+ rocketed 85%. Conversely, low-coverage plans below ₹10 lakh slumped 24% post-exemption and a steeper 29% year-on-year from 2024 signaling buyers are ditching minimal safety nets for robust armor.
This trend dovetails with broader currents reshaping India’s healthcare-financial nexus. Amid expansions like Kauvery’s North-East outreach, sovereign clouds securing data (L&T Vyoma’s alliances), and biologics manufacturing ramps (Kashiv’s ₹648 crore boost), the GST relief amplifies preventive momentum echoing NHA’s push for hyper-personalized care and AI platforms targeting early risks (TAKE Solutions). In a landscape where heart diseases, cancers, and cataracts top claims—joined by seasonal infections and accidents the shift toward higher sums and multi-year plans (gaining sharp popularity) reflects maturing awareness: protection isn’t optional; it’s proactive.
Geography adds intrigue. Tier-3 cities surged their share to 70% (from 63.5% in 2024), Tier-2 edged up marginally, while Tier-1 dipped suggesting aspirational India, buoyed by rising incomes and digital access, is driving penetration. Top booking cities like Delhi, Bengaluru, Hyderabad, Pune, and Mumbai retain urban pull, but deeper India is awakening.
Age demographics hold steady yet insightful: millennials (18-35) lead at 30%, followed by 35-45 (26%), with seniors (61+) at 21% all upgrading amid lifestyle disease spikes. This GST catalyst, layered on Ayushman Bharat’s foundations and quality enforcements (like UP’s HEM 2.0), isn’t just affordable it’s empowering millions to confront medical inflation head-on, forging a more resilient national health fabric.
“GST exemption has nudged buyers towards more robust coverage turning affordability into stronger, long-term protection for families across India.”
By
HB Team
